Daqian Gu

429 citations
8 papers · 298 indexed · h-index 7

Impact in

    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

Daqian Gu

7 papers receiving 296 citations

Peers

Daqian Gu
Comparison fields: 5 of 69
  • Immunology 100
  • Oncology 119
  • Nephrology 19
  • Cancer Research 35
  • Pulmonary and Respiratory Medicine 55
Replace Arnon Arazi with:
Arnon Arazi United States
Jinrui Dong Singapore
Surasak Wichaiyo Thailand
Yini Ke China
Xing Lyu China
Shuling Han China
Liqi Bi China
Shanjuan Hong China
Xiao Hu China
Daqian Gu relative to Arnon Arazi United States Arnon Arazi's profile →
Citations per field
00.5×1.5×
Arnon Arazi · 1×
Citations per year

Countries citing papers authored by Daqian Gu

Since Specialization
Citations

This map shows the geographic impact of Daqian Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daqian Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daqian Gu more than expected).

Fields of papers citing papers by Daqian Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daqian Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daqian Gu. The network helps show where Daqian Gu may publish in the future.

Co-authors

The 25 scholars most cited alongside Daqian Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daqian Gu Line = papers co-authored together Daqian Gu links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 2018201
2 202226
3 202121
4 202017
5 202117
6 20199
7 20237
8 20250

About Daqian Gu

Daqian Gu is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Biochemistry, Immunology and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 298 indexed citations. Recurring topics across this work include Heme Oxygenase-1 and Carbon Monoxide (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Sepsis Diagnosis and Treatment (1 paper), Diet, Metabolism, and Disease (1 paper), Apelin-related biomedical research (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Glutathione Transferases and Polymorphisms (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Immunology (100 citations), Oncology (119 citations), Nephrology (19 citations), Cancer Research (35 citations) and Pulmonary and Respiratory Medicine (55 citations). Daqian Gu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yu Yang, Xiang Xu, Xiang Ao, Zhuo Chen, Ziyue Zhang, Chunyu Zeng, Yu Han, Duofen He, Donghai Yang and Pedro A. José. Their work appears in journals such as Acta Pharmaceutica Sinica B, Life Sciences, Clinical and Experimental Pharmacology and Physiology, Clinical Science and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026